Nanopharmaceuticals Market: Overview

Nanopharmaceuticals are revolutionizing medical science by leveraging nanomedicine to render effective healthcare, especially in developing countries. The technology is yet in evolution stages and promises to bring advancement not only in therapeutics but also in detecting diseases and targets. Also, one factor that is making it popular is its cost-effectiveness.

Read Report Overview - https://www.transparencymarketresearch.com/nanopharmaceuticals-market.html

Rise in the incidence of chronic diseases such as infectious diseases, cancer, and cardiovascular diseases, is paving way for expansion of nano-pharmaceuticals market. Nanopharmaceuticals are also referred to as nanotechnology-based pharmaceuticals. The advancement is becoming an integral part of medical science and has potential to treat diseases at cellular level.

Primarily, nanopharmaceuticals are particles in the size range 10 to 1,000 nanometers of specific matter used to manufacture drugs. As a result of composition and shape, the medicines have several benefits to offer over the normal medicines.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=66464

The report on nanopharmaceuticals market offers insights about the latest developments in the field. Besides, it targets the potential drivers which will help in the expansion of the market in the tenure of forecast period. Later, the market intelligence offers details about particular segments dominating in specific regions.

Nano-pharmaceuticals Market: Trends and Opportunities

Increase in the incidence of chronic diseases such as cancer, infectious diseases, and cardiovascular diseases, is one of the main factors fuelling nano-pharmaceuticals market. Prominent players in the nano-pharmaceuticals market are investing on large scale in order to introduce improved medicines in the market.

Request for Analysis of COVID-19 Impact on Nano-pharmaceuticals Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=66464

The advancements in the nanopharmaceuticals are likely to address therapeutics for critical diseases, which are yet to be explored. This can be explained by an example of Jazz Pharmaceuticals, a key player of nano-pharmaceuticals market. In August 2017, the company received FDA approval for Vyxeos. Vyxeos is basically used for the treatment of acute myeloid leukemia.

Registering the pace of research and developments underway for nanopharmaceuticals, global nano-pharmaceuticals market is projected to grow at a significant pace in the course of the forecast period.

On the other side, factors such as less solubility of nano-pharmaceuticals, toxicity issues, and its functioning need to be addressed on a wider scale. If not, these factors may hinder the growth of the nanopharmaceutical market in the tenure of forecast period.

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=66464

Nanopharmaceuticals Market: Regional Outlook

As a result of substantial advancement in the research and development activities in North America, the region is expected to dominate in the global nano-pharmaceuticals market. Besides, the region is witnessing rapid adoption rate of nano-pharmaceuticals for advanced therapeutics. Also, presence of prominent players is another main factor which is fuelling the expansion of nano-pharmaceutical market.

Due to presence of large number of players in the nano-pharmaceuticals market, the competition is also intense. These players are bringing several strategies and developments in the market to gain foothold in the market. Prominent players are expanding their reign by acquisitions, merging and collaborations. Some of the prominent players in the market are- Teva Pharmaceuticals Industries Limited, JOHNSON & JOHNSON, Shire Plc., Novartis AG, Hoffmann-La Roche AG, Pfizer Inc., Merck & Co., and Sanofi S.A.

Pre Book Nano-pharmaceuticals Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=66464&ltype=S

Nano-pharmaceuticals Market: Competitive Analysis

Some of the key players in the nanopharmaceuticals market are JOHNSON & JOHNSON, Sanofi S.A, Hoffmann-La Roche AG, Teva Pharmaceuticals Industries Limited, Novartis AG, Merck & Co., Shire Plc., and Pfizer.

Browse more Trending Reports by Transparency Market Research:

Medical Animation Market: https://www.transparencymarketresearch.com/medical-animation-market.html

Chiropractic Care Market: https://www.transparencymarketresearch.com/chiropractic-care-market.html

Proton Therapy Market: https://www.transparencymarketresearch.com/proton-therapy-market.html

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

ContactMr. Rohit BhiseyTransparency Market ResearchState Tower,90 State Street,Suite 700,Albany NY - 12207United StatesUSA - Canada Toll Free: 866-552-3453Email: sales@transparencymarketresearch.comWebsite: https://www.transparencymarketresearch.com/

Read the original post:
Nanopharmaceuticals Market: Rise in the Incidence of Chronic Diseases is Expected to Drive the Market - BioSpace

April 14, 2020

Predictions about the disasters are useless, unless someone take a note of such predictions beforehand and be well prepared for the devastation or more effectively, prevent them from happening.

Yuval Noah Hariri is the celebrity author of the popular science bestsellers Sapiens: A Brief History of Humankind (2014), Homo Deus: A Brief History of Tomorrow (2016), and 21 Lessons for the 21st Century (2018).

In Sapiens he surveys the entire length of human history, from the evolution of Homo sapiens about 70000 years ago along with other human like species Homo neanderthals and Homo erectus, the development of their cognitive abilities, up to the political and technological revolutions of the 21st century.

Where as in Homo Deus he is examining possibilities of the future of Homo sapiens. The book's premise outlines that, in the future, humanity is likely to make a significant attempt to gain happiness, immortality and God-like powers. The book goes on to openly speculate various ways this ambition might be realised for Homo sapiens in the future based on the past and present. He predicts the possible consequences of a futuristic biotechnological world in which intelligent biological organisms are surpassed by their own creations. He speculate that we as a species will mutate ourselves into new God-like species, Homo Deus.

And we all believed that with its technological advancements in the fields of artificial intelligence (AI), bio technology and nano technology, human race is going to achieve that in the near future.

The scientific advancements in the field of AI predicted that by the year 2040, we would achieve technological singularity. Intelligence explosion, in which an upgradable intelligent agent will eventually enter a "runaway reaction" of self-improvement cycles, with each new and more intelligent generation appearing more and more rapidly, causing an 'explosion' in intelligence and resulting in a powerful superintelligence that may achieve self-awareness and qualitatively far surpasses all human intelligence.

The advancements in the field of medicines, bio technology and nano technology predicted that the death will be optional for us by the year 2040.

Advancements in space science and technology predicted that we will be capable of colonizing Moon, Mars and beyond.

We believed we have the best of the political systems governing the different parts of the world. Every system, be its communist, democratic, imperialistic or some other, boasted its own superiority over the other and claimed to be the best equipped to manage its population to the best of its knowledge. Most advanced countries boasted the best of the medical facilities that equipped to face any kind of medical problems, and ridiculed the others, the less privileged.

Our Gods and religious systems did not stay behind in this race and claimed the solutions to the each of the problems faced by the humanity and offered answers to the questions of our existence and purpose. Every God, every religion claimed its supremacy over the other and we did not hesitate to kill each other in the very name of the Gods supposed to protect and bring peace to humanity.

Then it hit us

Its not even a living thing. Just a few RNA (Ribonucleic Acid) strands covered with a protein sheath, so small that normal microscopes cant see it. It was there all along, but novel because of its new avatar or strain. It requires a living cell to start its activities and all it does is replicate itself. Nevertheless, in this process, it created havoc and chaos and succeeded to bring down the whole, mighty world down on its knees without any discrimination. The powerful, highly developed nations, their poor counterparts, democratic, communist or imperialistic, it treated them all the same. It did not see the religion, language, qualification, financial status, economical background or the geographical location and easily be termed as a great equalizer.

Yes, novel coronavirus.

We had several warnings. We had so many pandemics those wiped off millions of lives in the history. Apart from that, Bill Gates and former US President George W Bush and many others scientists and visionaries have warned well in advance about such out breaks and suggested the ways to be prepared.

There are few pictures and videos in social media going viral now about some books and movies, which predicted about the pandemics.

Funny thing about such predictions, including that of the famous Nostradamus are that they all surface after the event and everyone jumps into the bandwagon to say, Look, I told you so.

Predictions about the disasters are useless, unless someone take a note of such predictions beforehand and be well prepared for the devastation or more effectively, prevent them from happening.

Interestingly, in his latest book 21 Lessons for the 21st Century, Yuval Noah Hariri discusses about challenges and possible solutions for 21 different things like Work, Liberty, Equality, Religion, Immigration, Terrorism etc., but misses a Health Pandemic.

Our Gods, religious, political, technological and medical systems did not know what hit them. Its proved beyond doubt that all Gods and religious systems, all kinds of political systems, scientific advancements have failed in their current avatars and they are not equipped to face a pandemic of this kind.

There is not a solution in the horizon. We have not reached a plateau as of today and the number of positive cases and deaths are steadily rising all over the world. Moreover, nobody knows for sure if there will be a solution and if at all, when.

And if we survive this pandemic, and I dont know how many would survive, the world as we know will change. A change like never seen before. However, a change thats the need of the hour.

The survivors of this new world order need to sit together and retrospect about the way we ran our world so far. They should determine if they need Gods and Religions, and if yes, in which format? They need to revamp all the political, technological, economical and medical systems in their current avatars and design totally new effective systems which are well equipped to run the world in a just and fair way.

A new world that gives every human being an equal opportunity of existence and well-being.

The Risen Ape is yet to find its ground in the larger schemes of things.

Read more here:
The World on its Knees - Daijiworld.com

A new market report by Market Research Intellect on the Nanomedicine Market has been released with reliable information and accurate forecasts for a better understanding of the current and future market scenarios. The report offers an in-depth analysis of the global market, including qualitative and quantitative insights, historical data, and estimated projections about the market size and share in the forecast period. The forecasts mentioned in the report have been acquired by using proven research assumptions and methodologies. Hence, this research study serves as an important depository of the information for every market landscape. The report is segmented on the basis of types, end-users, applications, and regional markets.

The research study includes the latest updates about the COVID-19 impact on the Nanomedicine sector. The outbreak has broadly influenced the global economic landscape. The report contains a complete breakdown of the current situation in the ever-evolving business sector and estimates the aftereffects of the outbreak on the overall economy.

Get Sample Copy with TOC of the Report to understand the structure of the complete report @ https://www.marketresearchintellect.com/download-sample/?rid=201321&utm_source=COD&utm_medium=888

The report also emphasizes the initiatives undertaken by the companies operating in the market including product innovation, product launches, and technological development to help their organization offer more effective products in the market. It also studies notable business events, including corporate deals, mergers and acquisitions, joint ventures, partnerships, product launches, and brand promotions.

Leading Nanomedicine manufacturers/companies operating at both regional and global levels:

Sales and sales broken down by Product:

Sales and sales divided by Applications:

The report also inspects the financial standing of the leading companies, which includes gross profit, revenue generation, sales volume, sales revenue, manufacturing cost, individual growth rate, and other financial ratios.

The report also focuses on the global industry trends, development patterns of industries, governing factors, growth rate, and competitive analysis of the market, growth opportunities, challenges, investment strategies, and forecasts till 2026. The Nanomedicine Market was estimated at USD XX Million/Billion in 2016 and is estimated to reach USD XX Million/Billion by 2026, expanding at a rate of XX% over the forecast period. To calculate the market size, the report provides a thorough analysis of the market by accumulating, studying, and synthesizing primary and secondary data from multiple sources.

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=201321&utm_source=COD&utm_medium=888

The market is predicted to witness significant growth over the forecast period, owing to the growing consumer awareness about the benefits of Nanomedicine. The increase in disposable income across the key geographies has also impacted the market positively. Moreover, factors like urbanization, high population growth, and a growing middle-class population with higher disposable income are also forecasted to drive market growth.

According to the research report, one of the key challenges that might hinder the market growth is the presence of counter fit products. The market is witnessing the entry of a surging number of alternative products that use inferior ingredients.

Key factors influencing market growth:

Reasons for purchasing this Report from Market Research Intellect

Customized Research Report Using Corporate Email Id @ https://www.marketresearchintellect.com/need-customization/?rid=201321&utm_source=COD&utm_medium=888

Customization of the Report:

Market Research Intellect also provides customization options to tailor the reports as per client requirements. This report can be personalized to cater to your research needs. Feel free to get in touch with our sales team, who will ensure that you get a report as per your needs.

Thank you for reading this article. You can also get chapter-wise sections or region-wise report coverage for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

To summarize, the Nanomedicine market report studies the contemporary market to forecast the growth prospects, challenges, opportunities, risks, threats, and the trends observed in the market that can either propel or curtail the growth rate of the industry. The market factors impacting the global sector also include provincial trade policies, international trade disputes, entry barriers, and other regulatory restrictions.

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage and more. These reports deliver an in-depth study of the market with industry analysis, market value for regions and countries and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Read more here:
Nanomedicine Market 2019 Break Down by Top Companies, Countries, Applications, Challenges, Opportunities and Forecast 2026 - Cole of Duty

Healthcare Nanotechnology Market2020-2025 report offerscomprehensive quantitative and qualitative market analysis. This report has been prepared under the continuous observation of the global market situation. This report has been formulated to give our clients the most up to date data and analyses of the Healthcare Nanotechnology Market. The impact on the enterprises and business development, distribution by region and global level is assessed in the report.

Top Companies are covering This Report:-

AmgenStrykerTeva PharmaceuticalsUCBRocheAbbottMerck & CoCelgeneBiogenSanofiLeadiant BiosciencesShireKyowa Hakko KirinGilead SciencesJohnson & Johnson3M CompanyEndo InternationalSmith & NephewPfizerIpsen

The research process involved the study of various factors affecting the industry such as government policy, market environment, competitive landscape, historical data, existing trends in the market, and market risks, opportunities, market barriers and challenges.

Reports Intellect projects Healthcare Nanotechnology Market based on elite players, present, past, and forecast data for the coming years which will act as a profitable guide for all the market competitors. The study includes growth trends, micro- economic and macro-economic indicators in detail and the report has been assessed with the help of PESTEL analysis and other essential analyses operating in the Healthcare Nanotechnology Market. Top-down and bottom-up approaches are used to validate the global Healthcare Nanotechnology market size and estimate the market size for Company, regions segments, product segments and Application.

Get Sample PDF Brochure @https://www.reportsintellect.com/sample-request/905451

The report offers all the essential data for players to secure a position of strength in the market, all while creating a comprehensive action plan. Our analysts here at Reports Intellect have used advanced primary and secondary research techniques to create the most up to date assessment of data on the Healthcare Nanotechnology Market which opens up a plethora of new opportunities to create new strategies to gain leverage over the competition.

Type Coverage:

NanomedicineNano Medical DevicesNano DiagnosisOthersNanomedicine has the highest percentage of revenue by type, with more than 86% in 2019.

Application Coverage:

AnticancerCNS ProductAnti-infectiveOthersAccording to the application, anticancer and CNS products accounted for 17.56% and 22.70% of the market in 2019 respectively.

Market Segment by Regions, regional analysis covers

North America Country (United States, Canada)

South America

Asia Country (China, Japan, India, Korea)

Europe Country (Germany, UK, France, Italy)

Other Country (Middle East, Africa, GCC)

Discount PDF Brochure @https://www.reportsintellect.com/discount-request/905451

Why us:

Reasons to buy:

About Us:-

Contact Us:

Sales@reportsintellect.com

PH + 1-706-996-2486

US Address:

225 Peachtree Street NE,

Suite 400,

Atlanta, GA 30303

Follow this link:
Healthcare Nanotechnology Market Insights Competitive Analysis and Future Demand and Revenue Forecast to 2024 | Key Companies: Amgen, Stryker, Teva...

Nanomedicine is one of the applications of nanotechnology used in diagnosis, treatment, monitoring, and control of biological systems. Nanomedicine uses nanoscale manipulation of materials to improve medicine delivery. Thus, nanomedicine has facilitated the treatment against various diseases. Nanomedicine is in nascent stage, as several products are in the development phase. According to Nanobiotix (a nanomedicine company), in 2015, around 230 nanomedicine products were identified, which are either marked or are in the trial phase.

Get the PDF Sample Copy of this Report:

https://www.a2zmarketresearch.com/sample?reportId=20562

This report covers Nanomedicines market from the bottom line, starting from its definition. Later, it segments the market on various criteria to give a depth of understanding on the various product types and pricing structures and applications. Each and every segment is examined carefully by factoring in sales, revenue and market size in order to understand the potential of growth and scope.

Various factors are responsible for the markets growth trajectory, which are studied at length in the report. In addition, the report lists down the restraints that are posing threat to the global Nanomedicines market. It also gauges the bargaining power of suppliers and buyers, threat from new entrants and product substitute, and the degree of competition prevailing in the market. The influence of the latest government guidelines is also analyzed in detail in the report. It studies the Nanomedicines markets trajectory between forecast periods.

Some of the Top Companies Profiled in this Market includes:

Global Nanomedicines Market Segmentation:

Market Segmentation: By Product

Market Segmentation: By Nanomolecule Type

Market Segmentation: By Application

Get Special Discount Upto 30% on this Report:

https://www.a2zmarketresearch.com/discount?reportId=20562

Key questions answered in the report include:

Table of Contents

Global Nanomedicines Market Research Report

Chapter 1 Nanomedicines Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global Nanomedicines Market Forecast

Buy Exclusive Research Report:

https://www.a2zmarketresearch.com/buy?reportId=20562

If you have any special requirements, please let us know and we will offer you the report as you want.

See the rest here:
Nanomedicines Market will touch a new level in upcoming year with Top Key Players like Abbott, GE Healthcare, Johnson & Johnson, Merck, Pfizer,...

June 5, 2020

In an op-ed for the New York Times, Adnan Hirad 20M (MD/PhD) contends that disinformationor the deliberate spreading of false or misleading informationabout COVID-19 has metastasized among Somalis in the United States and abroad.

This coronavirus disinformation sometimes takes the form of WhatsApp messages about homeopathy remedies, such as drinking warm water, eating garlic, and applying black seed oil every day to prevent COVID-19. Other times, it manifests as subtitled videos asserting that Bill Gates is funding coronavirus vaccine research in order to implant and track people with nano-size microchips.

Writes Hirad, it is scary that these messages are being used to terrorize vulnerable populations already struggling with the enormous disruptions of a pandemic. Yet, he notes:

How, when, where and why these messages spread through a network of Somalis inside and outside the United States remains a question. Does each ethnic community have its own special network of disinformation?

Hirad, a recent graduate of the Medical Scientist Training Program at the University of Rochesters School of Medicine and Dentistry, explains that he was taught to consider the interconnectedness of a patients social, psychological, as well as biological factors. For some patients, these factors might include a mistrust of Western-endorsed public health campaignswhich anti-vaccine advocates can prey on. In Minnesota in 2017, the consequence of this mistrust in medical expertise was a measles outbreak in the Somali-American community.

To compete for the hearts and minds of communities against viral misinformation, public health approaches have to be organized around both national and local cultural touchstones, Hirad writes. Such public health efforts to combat misinformation should start now.

Tags: alumni, COVID-19, School of Medicine and Dentistry

Category: Voices & Opinion

Original post:
Time to combat coronavirus disinformation in ethnic communities - University of Rochester

Products

Marketing Statements

CBD Products

CBD products

CBD products

CBD products

CBD products

CBD products

CBD products

CBD products

Dietary Supplements and Vitamins

Vitamin C product

Vitamin D products

Super C, Vitamin D/K2, Zinc Charge, and Immuno-Strong Berry Liquid

NoronaPak products, including supplement products

Dietary supplements

Grapefruit seed extract, colostrum, and cod liver oil products

Essential Oils

Essential oils and dietary supplements

Essential oil products

Essential oil products

Essential oil products

Essential oil products

Essential oil products

Essential oil products

Essential oils and herbal products

Herbal Products

Herbal products

Herbal products

Herbal products

Herbal tinctures and herbal remedy products

Herbal products including CoronaDefender Herbal Sachet-S

Herbal products, including Carahealth Immune

Coronavirus Protocol (Coronavirus Boneset Tea, Coronavirus Cell Protection, Coronavirus Core tincture, Coronavirus Immune System, and Elderberry Tincture)

Formula #1, Formula #2, Formula #3, and Eupatorium perfoliatum (Boneset)

Homeopathic Products

Homeopathic Genus Epidemicus

Homeopathic drugs and dietary supplement products

Homeopathic drug products

Homeopathic drugs

Sanitizer/Antimicrobial Products

Non-alcohol based hand sanitizer product

Non-alcohol based sanitizer products

Prefense Hand Sanitizers

Germ Stopper products

Sani-Bar GK95 and Sani-Disc GK95D

Products labeled to contain Silver

Colloidal silver products

Colloidal silver products

Colloidal silver products

Products labeled to contain silver

Silver Sol Liquid and products labeled to contain silver

Quicksilver Liposomal Vitamin C w/ Liposomal, Jigsaw Magnesium With SRT, and products labeled to contain silver

Superblue Silver Immune Gargle, SuperSilver Whitening Toothpaste, SuperSilver Wound Dressing Gel and Superblue Fluoride Free Toothpaste

HealthMax Nano-Silver Liquid, Silver Biotics Silver Lozenges with Vitamin C, and Silver Biotics Silver Gel Ultimate Skin & Body Care (collectively, your silver products)

Colloidal silver, vitamins, minerals, herb oils, and a homeopathic drug product

Liquid Silver, Camu Camus Vitamin C, Vitaly C, Immunity Kit, Vitamin D3-K2, and Power Immune

Silver, CBD products, iodine, medicinal mushroom, selenium, zinc, vitamin C, vitamin D3, astragalus, and elderberry

Other Products

Miracle Mineral Solution (MMS) (chlorine dioxide)

Fortify Humic Beverage Concentrate and Electrify Fulvic Beverage Concentrate

Honey product, COVID-19 COUGH Syrup

Salt therapy products

FullerLifeC60

Viral Defense Tincture

Traditional Chinese medicine products

China Oral Nosode, described as AN330 CORONA VIRAL IMMUNE SUPPORT AND/OR ACTIVE RESPIRATORY INFECTION FOR ALL AGES

Kratom products

Ayurvedic products

nCoV19 spike protein vaccine

CORE and IMMUNE SHOT

Defend Patch

NAD+ and NMN sublingual gel products

Corona-Cure Coronavirus Infection Prevention Nasal Spray

Viral Protection Kits

See the original post here:
How FDA Is Monitoring The COVID-19 Product Market - JD Supra

New York, June 05, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Foot Care Products Industry" - https://www.reportlinker.com/p090579/?utm_source=GNW An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Medicine market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.

As part of the new emerging geographic scenario, the United States is forecast to readjust to a 4.6% CAGR. Within Europe, the region worst hit by the pandemic, Germany will add over US$1.1 Million to the regions size over the next 7 to 8 years. In addition, over US$1.1 Million worth of projected demand in the region will come from Rest of European markets. In Japan, the Medicine segment will reach a market size of US$2.9 Million by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Foot Care Products market. Against this backdrop and the changing geopolitical, business and consumer sentiments, the worlds second largest economy will grow at 9.8% over the next couple of years and add approximately US$10.2 Million in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Foot Care Products market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, Aetna Felt Corporation; Aetrex Worldwide, Inc.; Alva-Amco Pharmacal Companies, Inc.; Bayer AG; Blistex Inc.; Chattem, Inc.; Footcare Express Inc.; GlaxoSmithKline Plc; Implus LLC; Johnson & Johnson; Miracle of Aloe; Pacific World Corporation; PediFix, Inc.; ProFoot, Inc.; RG Barry Corporation; Spenco Medical Corporation; Tweezerman International LLC; Xenna Corporation

Read the full report: https://www.reportlinker.com/p090579/?utm_source=GNW

FOOT CARE PRODUCTS MCP-1MARKET ANALYSIS, TRENDS, AND FORECASTS, JUNE 2CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW Foot Care Products Market - A Prelude Recent Market Activity Asia-Pacific - The Fastest Growing Market Foot Care Segments Exhibiting Varied Growth Rates Global Competitor Market Shares Foot Care Products Competitor Market Share Scenario Worldwide (in %): 2018 & 2029 Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS Aetna Felt Corporation (USA) Aetrex Worldwide, Inc. (USA) Alva-Amco Pharmacal Companies, Inc. (USA) Bayer AG (Germany) Blistex Inc. (USA) Chattem, Inc. (USA) Footcare Express Inc. (USA) Footlogix Pediceuticals (Canada) GlaxoSmithKline Plc. (UK) HoMedics, Inc. (USA) Implus LLC (USA) Johnson & Johnson (USA) Miracle of Aloe (USA) Pacific World Corporation (USA) PediFix, Inc. (USA) ProFoot, Inc. (USA) RG Barry Corporation (USA) Spenco Medical Corporation (USA) Tweezerman International LLC (USA) Xenna Corporation (USA) 3. MARKET TRENDS & DRIVERS Aging Population Offers Growth Prospects The Emerging Middle Class in Developing Countries to Fuel Market Women: An Important Consumer Cluster Rising Interest in Grooming Among Men Signals Opportunities Product Innovations Pioneer Growth Innovations in Foot-Care Medication to Expand Opportunities Device Innovations - Key to Growth Growing Awareness and Product Innovations Drive Demand for Foot Insoles Focused Insole Makers See Growing Opportunities New Antifungal Treatments Promise Higher Efficacy Nanomedicine to Improve Anti-Fungal Treatment E-Retailing Expands Growth Opportunities Significance of Foot-Care in Diabetic Population - A Prelude Smart Socks - The Future of Diabetic Foot Care? Obese Population - A Weighty Market Driver Price - Important Factor in Foot Care Market Natural Remedies - A Challenge? 4. GLOBAL MARKET PERSPECTIVE Table 1: Foot Care Products Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027 Table 2: Foot Care Products Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2012-2019 Table 3: Foot Care Products Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027 Table 4: Medicine (Type) World Market by Region/Country in US$ Thousand: 2020 to 2027 Table 5: Medicine (Type) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to 2019 Table 6: Medicine (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027 Table 7: Device (Type) Potential Growth Markets Worldwide in US$ Thousand: 2020 to 2027 Table 8: Device (Type) Historic Market Perspective by Region/Country in US$ Thousand: 2012 to 2019 Table 9: Device (Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027 Table 10: Beauty Product (Type) Geographic Market Spread Worldwide in US$ Thousand: 2020 to 2027 Table 11: Beauty Product (Type) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2012 to 2019 Table 12: Beauty Product (Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027 III. MARKET ANALYSIS GEOGRAPHIC MARKET ANALYSIS UNITED STATES Market Facts & Figures US Foot Care Products Market Share (in %) by Company: 2018 & 2025 Market Analytics Table 13: United States Foot Care Products Market Estimates and Projections in US$ Thousand by Type: 2020 to 2027 Table 14: Foot Care Products Market in the United States by Type: A Historic Review in US$ Thousand for 2012-2019 Table 15: United States Foot Care Products Market Share Breakdown by Type: 2012 VS 2020 VS 2027 CANADA Table 16: Canadian Foot Care Products Market Estimates and Forecasts in US$ Thousand by Type: 2020 to 2027 Table 17: Canadian Foot Care Products Historic Market Review by Type in US$ Thousand: 2012-2019 Table 18: Foot Care Products Market in Canada: Percentage Share Breakdown of Sales by Type for 2012, 2020, and 2027 JAPAN Table 19: Japanese Market for Foot Care Products: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2020-2027 Table 20: Foot Care Products Market in Japan: Historic Sales Analysis in US$ Thousand by Type for the Period 2012-2019 Table 21: Japanese Foot Care Products Market Share Analysis by Type: 2012 VS 2020 VS 2027 CHINA Table 22: Chinese Foot Care Products Market Growth Prospects in US$ Thousand by Type for the Period 2020-2027 Table 23: Foot Care Products Historic Market Analysis in China in US$ Thousand by Type: 2012-2019 Table 24: Chinese Foot Care Products Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027 EUROPE Market Facts & Figures European Foot Care Products Market: Competitor Market Share Scenario (in %) for 2018 & 2025 Market Analytics Table 25: European Foot Care Products Market Demand Scenario in US$ Thousand by Region/Country: 2020-2027 Table 26: Foot Care Products Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2012-2019 Table 27: European Foot Care Products Market Share Shift by Region/Country: 2012 VS 2020 VS 2027 Table 28: European Foot Care Products Market Estimates and Forecasts in US$ Thousand by Type: 2020-2027 Table 29: Foot Care Products Market in Europe in US$ Thousand by Type: A Historic Review for the Period 2012-2019 Table 30: European Foot Care Products Market Share Breakdown by Type: 2012 VS 2020 VS 2027 FRANCE Table 31: Foot Care Products Market in France by Type: Estimates and Projections in US$ Thousand for the Period 2020-2027 Table 32: French Foot Care Products Historic Market Scenario in US$ Thousand by Type: 2012-2019 Table 33: French Foot Care Products Market Share Analysis by Type: 2012 VS 2020 VS 2027 GERMANY Table 34: Foot Care Products Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2020-2027 Table 35: German Foot Care Products Historic Market Analysis in US$ Thousand by Type: 2012-2019 Table 36: German Foot Care Products Market Share Breakdown by Type: 2012 VS 2020 VS 2027 ITALY Table 37: Italian Foot Care Products Market Growth Prospects in US$ Thousand by Type for the Period 2020-2027 Table 38: Foot Care Products Historic Market Analysis in Italy in US$ Thousand by Type: 2012-2019 Table 39: Italian Foot Care Products Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027 UNITED KINGDOM Table 40: United Kingdom Market for Foot Care Products: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2020-2027 Table 41: Foot Care Products Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Type for the Period 2012-2019 Table 42: United Kingdom Foot Care Products Market Share Analysis by Type: 2012 VS 2020 VS 2027 SPAIN Table 43: Spanish Foot Care Products Market Estimates and Forecasts in US$ Thousand by Type: 2020 to 2027 Table 44: Spanish Foot Care Products Historic Market Review by Type in US$ Thousand: 2012-2019 Table 45: Foot Care Products Market in Spain: Percentage Share Breakdown of Sales by Type for 2012, 2020, and 2027 RUSSIA Table 46: Russian Foot Care Products Market Estimates and Projections in US$ Thousand by Type: 2020 to 2027 Table 47: Foot Care Products Market in Russia by Type: A Historic Review in US$ Thousand for 2012-2019 Table 48: Russian Foot Care Products Market Share Breakdown by Type: 2012 VS 2020 VS 2027 REST OF EUROPE Table 49: Rest of Europe Foot Care Products Market Estimates and Forecasts in US$ Thousand by Type: 2020-2027 Table 50: Foot Care Products Market in Rest of Europe in US$ Thousand by Type: A Historic Review for the Period 2012-2019 Table 51: Rest of Europe Foot Care Products Market Share Breakdown by Type: 2012 VS 2020 VS 2027 ASIA-PACIFIC Table 52: Asia-Pacific Foot Care Products Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027 Table 53: Foot Care Products Market in Asia-Pacific: Historic Market Analysis in US$ Thousand by Region/Country for the Period 2012-2019 Table 54: Asia-Pacific Foot Care Products Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027 Table 55: Foot Care Products Market in Asia-Pacific by Type: Estimates and Projections in US$ Thousand for the Period 2020-2027 Table 56: Asia-Pacific Foot Care Products Historic Market Scenario in US$ Thousand by Type: 2012-2019 Table 57: Asia-Pacific Foot Care Products Market Share Analysis by Type: 2012 VS 2020 VS 2027 AUSTRALIA Table 58: Foot Care Products Market in Australia: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2020-2027 Table 59: Australian Foot Care Products Historic Market Analysis in US$ Thousand by Type: 2012-2019 Table 60: Australian Foot Care Products Market Share Breakdown by Type: 2012 VS 2020 VS 2027 INDIA Table 61: Indian Foot Care Products Market Estimates and Forecasts in US$ Thousand by Type: 2020 to 2027 Table 62: Indian Foot Care Products Historic Market Review by Type in US$ Thousand: 2012-2019 Table 63: Foot Care Products Market in India: Percentage Share Breakdown of Sales by Type for 2012, 2020, and 2027 SOUTH KOREA Table 64: Foot Care Products Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2020-2027 Table 65: South Korean Foot Care Products Historic Market Analysis in US$ Thousand by Type: 2012-2019 Table 66: Foot Care Products Market Share Distribution in South Korea by Type: 2012 VS 2020 VS 2027 REST OF ASIA-PACIFIC Table 67: Rest of Asia-Pacific Market for Foot Care Products: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2020-2027 Table 68: Foot Care Products Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Thousand by Type for the Period 2012-2019 Table 69: Rest of Asia-Pacific Foot Care Products Market Share Analysis by Type: 2012 VS 2020 VS 2027 LATIN AMERICA Table 70: Latin American Foot Care Products Market Trends by Region/Country in US$ Thousand: 2020-2027 Table 71: Foot Care Products Market in Latin America in US$ Thousand by Region/Country: A Historic Perspective for the Period 2012-2019 Table 72: Latin American Foot Care Products Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027 Table 73: Latin American Foot Care Products Market Growth Prospects in US$ Thousand by Type for the Period 2020-2027 Table 74: Foot Care Products Historic Market Analysis in Latin America in US$ Thousand by Type: 2012-2019 Table 75: Latin American Foot Care Products Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027 ARGENTINA Table 76: Argentinean Foot Care Products Market Estimates and Forecasts in US$ Thousand by Type: 2020-2027 Table 77: Foot Care Products Market in Argentina in US$ Thousand by Type: A Historic Review for the Period 2012-2019 Table 78: Argentinean Foot Care Products Market Share Breakdown by Type: 2012 VS 2020 VS 2027 BRAZIL Table 79: Foot Care Products Market in Brazil by Type: Estimates and Projections in US$ Thousand for the Period 2020-2027 Table 80: Brazilian Foot Care Products Historic Market Scenario in US$ Thousand by Type: 2012-2019 Table 81: Brazilian Foot Care Products Market Share Analysis by Type: 2012 VS 2020 VS 2027 MEXICO Table 82: Foot Care Products Market in Mexico: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2020-2027 Table 83: Mexican Foot Care Products Historic Market Analysis in US$ Thousand by Type: 2012-2019 Table 84: Mexican Foot Care Products Market Share Breakdown by Type: 2012 VS 2020 VS 2027 REST OF LATIN AMERICA Table 85: Rest of Latin America Foot Care Products Market Estimates and Projections in US$ Thousand by Type: 2020 to 2027 Table 86: Foot Care Products Market in Rest of Latin America by Type: A Historic Review in US$ Thousand for 2012-2019 Table 87: Rest of Latin America Foot Care Products Market Share Breakdown by Type: 2012 VS 2020 VS 2027 MIDDLE EAST Table 88: The Middle East Foot Care Products Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027 Table 89: Foot Care Products Market in the Middle East by Region/Country in US$ Thousand: 2012-2019 Table 90: The Middle East Foot Care Products Market Share Breakdown by Region/Country: 2012, 2020, and 2027 Table 91: The Middle East Foot Care Products Market Estimates and Forecasts in US$ Thousand by Type: 2020 to 2027 Table 92: The Middle East Foot Care Products Historic Market by Type in US$ Thousand: 2012-2019 Table 93: Foot Care Products Market in the Middle East: Percentage Share Breakdown of Sales by Type for 2012,2020, and 2027 IRAN Table 94: Iranian Market for Foot Care Products: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2020-2027 Table 95: Foot Care Products Market in Iran: Historic Sales Analysis in US$ Thousand by Type for the Period 2012-2019 Table 96: Iranian Foot Care Products Market Share Analysis by Type: 2012 VS 2020 VS 2027 ISRAEL Table 97: Israeli Foot Care Products Market Estimates and Forecasts in US$ Thousand by Type: 2020-2027 Table 98: Foot Care Products Market in Israel in US$ Thousand by Type: A Historic Review for the Period 2012-2019 Table 99: Israeli Foot Care Products Market Share Breakdown by Type: 2012 VS 2020 VS 2027 SAUDI ARABIA Table 100: Saudi Arabian Foot Care Products Market Growth Prospects in US$ Thousand by Type for the Period 2020-2027 Table 101: Foot Care Products Historic Market Analysis in Saudi Arabia in US$ Thousand by Type: 2012-2019 Table 102: Saudi Arabian Foot Care Products Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027 UNITED ARAB EMIRATES Table 103: Foot Care Products Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2020-2027 Table 104: United Arab Emirates Foot Care Products Historic Market Analysis in US$ Thousand by Type: 2012-2019 Table 105: Foot Care Products Market Share Distribution in United Arab Emirates by Type: 2012 VS 2020 VS 2027 REST OF MIDDLE EAST Table 106: Foot Care Products Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2020-2027 Table 107: Rest of Middle East Foot Care Products Historic Market Analysis in US$ Thousand by Type: 2012-2019 Table 108: Rest of Middle East Foot Care Products Market Share Breakdown by Type: 2012 VS 2020 VS 2027 AFRICA Table 109: African Foot Care Products Market Estimates and Projections in US$ Thousand by Type: 2020 to 2027 Table 110: Foot Care Products Market in Africa by Type: A Historic Review in US$ Thousand for 2012-2019 Table 111: African Foot Care Products Market Share Breakdown by Type: 2012 VS 2020 VS 2027 IV. COMPETITION

Total Companies Profiled: 119 Read the full report: https://www.reportlinker.com/p090579/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

View post:
Amid the COVID-19 crisis and the looming economic recession, the Foot Care Products market worldwide will grow by a projected US$37.8 Million, during...

Global Nanotechnology Drug Delivery Marketwas valued US$ XX Bn in 2018 and is expected to reach US$ 98.2 Bn by 2026, at a XX% CAGR of around during a forecast period.

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

Various novel technologies for developing effective drug delivery systems came into existence among which nanotechnology platforms for achieving targeted drug delivery are gaining prominence nowadays. Research in the medical field includes the development of drug nanoparticles, polymeric and inorganic biodegradable nano-carriers for drug delivery, and surface engineering of carrier molecules.

REQUEST FOR FREE SAMPLE REPORT:https://www.maximizemarketresearch.com/request-sample/39035

The report contains a detailed list of factors that will drive and restrain the growth of the Nanotechnology Drug Delivery Market. Such as, rapidly expanding areas of research and development to develop novel nano-medicine are expected to drive the nanotechnology drug delivery market growth in the future. Additionally, one of the major factors assisting market growth is the growing prevalence of infectious diseases and cancer, developing nanotechnology research, and increasing demand for novel drug delivery systems. However, high cost coupled with stringent regulatory scenario hinders the market growth to some extent.

Nanoparticles are expected to account for the largest XX% market share by 2026. The segment dominated the market as key nanoparticles like gold nanoparticles, dendrimers, and fullerenes are used in pharmaceutical drug delivery.The report offers a brief analysis of the major regions in the global nanotechnology drug delivery market, namely, APAC, Europe, North America, South America, and the Middle East & Africa. North America dominated the nanotechnology drug delivery market in 2018, because of high medical reimbursement facilities, and technological advancement. The APAC is projected to have the fastest growth, owing to a rapidly increasing population, an increase in consumer awareness, favorable government policies, modernization of healthcare infrastructure, and growing medical tourism industry in developing economies such as China, and India in this region.

Nanotechnology drug delivery market report gives a competitive analysis of the individual standing of the companies against the global landscape of the medical industry. The forecast also provides the estimated trends in demand for the global market and their impact on the sizes of these companies to help the reader curate profitable business strategies. Such as Pfizer, Inc., AstraZeneca and Amgen signed agreements to collaborate with BIND Therapeutics to develop nano-medicines. These initiatives are expected to fuel the growth of the nanotechnology drug delivery market in the upcoming future.

The objective of the report is to present comprehensive analysis of Global Nanotechnology Drug Delivery Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers.

The report also helps in understanding Global Nanotechnology Drug Delivery Market dynamics, structure by analyzing the market segments, and project the Global Nanotechnology Drug Delivery Market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Nanotechnology Drug Delivery Market make the report investors guide.

DO INQUIRY BEFORE PURCHASING REPORT HERE:https://www.maximizemarketresearch.com/inquiry-before-buying/39035

Scope of the Global Nanotechnology Drug Delivery Market

Global Nanotechnology Drug Delivery Market, by Technology

Nanocrystals Nanoparticleso Dendrimerso Gold Nanoparticleso Dendrimerso Fullereneso Others Liposomes Micelles Nanotubes OthersGlobal Nanotechnology Drug Delivery Market, by Application

Neurology Oncology Cardiovascular/Physiology Anti-inflammatory/Immunology Anti-infective OthersGlobal Nanotechnology Drug Delivery Market, by Region

North America Asia Pacific Europe Middle East & Africa South AmericaKey players operating in the Global Nanotechnology Drug Delivery Market

Johnson & Johnson Merck & Co Roche Bayer Novartis Pharmaceuticals Pfizer AstraZeneca Amgen Celgene Corporation Angiotech Pharmaceuticals Capsulution Pharma AlphaRx Inc. Calando Pharmaceuticals Copernicus Therapeutics Elan Corporation Nanotherapeutics PAR Pharmaceutica Taiwan Liposome Co. AbbVie, Inc Amgen, Inc

MAJOR TOC OF THE REPORT

Chapter One: Nanotechnology Drug Delivery Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three: Global Nanotechnology Drug Delivery Market Competition, by Players

Chapter Four: Global Nanotechnology Drug Delivery Market Size by Regions

Chapter Five: North America Nanotechnology Drug Delivery Revenue by Countries

Chapter Six: Europe Nanotechnology Drug Delivery Revenue by Countries

Chapter Seven: Asia-Pacific Nanotechnology Drug Delivery Revenue by Countries

Chapter Eight: South America Nanotechnology Drug Delivery Revenue by Countries

Chapter Nine: Middle East and Africa Revenue Nanotechnology Drug Delivery by Countries

Chapter Ten: Global Nanotechnology Drug Delivery Market Segment by Type

Chapter Eleven: Global Nanotechnology Drug Delivery Market Segment by Application

Chapter Twelve: Global Nanotechnology Drug Delivery Market Size Forecast (2019-2026)

Browse Full Report with Facts and Figures of Nanotechnology Drug Delivery Market Report at:https://www.maximizemarketresearch.com/market-report/global-nanotechnology-drug-delivery-market/39035/

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Vikas Godage

Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Contact: +919607065656/ +919607195908

Website:www.maximizemarketresearch.com

View post:
Global Nanotechnology Drug Delivery Market: Industry Analysis and Forecast (2019-2026): By Technology, Application and Region - Azizsalon News

Many of us have traumatic memories of going to the doctor to get the flu shot or childhood vaccines when we were younger. This feeling isnt uncommon as 17 per cent of the population suers from anxiety or needle phobia. Your child self wasnt being irrational eitherneedles have proven to be a pain for the medical industry as well.

Although the transdermal patch has gained popularity over the years as an innovative way to deliver medicine into ones system, jet injectors have also made waves due to their benefits in rapid administration, improved dosing accuracy, faster response rates, better diffusion into tissues, and reduced sharps waste, according to a report by Grand View Research.

For those who dread needles, a solution is on the way, and its becoming a much more pervasive method of delivering drugs, without the associated fear. As needles become outdated, Inolife R&D is working on a method to implement needle-free injections with its pipeline of prototypes for the next generation of technology.

The point of needle-free

Inolife is an emerging specialty medical device company focused on developing and commercializing novel drug delivery technologies. The company commercializes FDA-cleared and CE approved needle-free injection systems catering to a wide range of applications. Being CE approved is particularly impressive as it means that they are conform to all health, safety and environmental concerns in Europe, which are among the strictest in the world. They have also long been focused on research and development, having acquired Dutch company, European Pharmagroup, to tap into their existing global knowledge base.

Michael Wright, CEO and President, Inolife R&D.

The need for needle-free injectors goes far beyond visits to the doctor for vaccines, and the potential market benefit is massive. Some of these applications include potential use for diabetes, dental anesthesia, vaccinations, autoimmune disease, erectile dysfunction, cancer treatments, growth hormones, cosmetics (for injections of Hyaluronic Acid and similar products), and veterinary applications.

Diabetes is especially one of the fastest-growing diseases around the globeit is estimated that 374 millionpeople are at increased risk of developing type 2 diabetes.Dr. Ricordi, M.D., and Inolifes Advisory Board member, works closely with the company on improving solutions for diabetics.

He explains his involvement, "It is my professional life mission to help people who have diabetes. Inolife's synergistic mission makes us excellent strategic partners. Their technology allows diabetes patients to inject their medication without needles, with the objective of increasing care plan compliance and improving overall outcomes.

I look forward to working with Inolife to positively impact the world through novel drug delivery system development.

Inolife is bringing to market injectors that can allow for at-home insulin injections, entirely without the usage of a needle. As Michael Wright, CEO and President of Inolife notes, Cross-contamination when handling needles is a major concern globally.

Our devices have no needles and do not perforate the skin while injecting and therefore, the risk of a needlestick injury is eliminated and when done, it does not require the same costly process for disposal as a biohazard. It can be discarded or eventually recycled.

Moreover, needles are dangerous and complicated to dispose of, providing a serious biohazard after use. Many viruses can live up to 48 hours on a needle, and special biohazard bins are needed for disposal. With no needle, these concerns vanish.

Not just in science fiction

So how exactly do you inject without a needle? While each product in the Inolife family is slightly different, they all work on the same principle. Regular needles work by puncturing the skin to deliver a pool of liquid into the tissue, but the Inolife needle-free injectors deliver the fluid just under the epidermis in the subcutaneous layer by a fine high-speed jet stream.

Because there is no needle penetrating the skin, theres a smaller chance of infection. Its also much more efficient, as the medicine spreads out evenly, rather than creating a pooling effectso in the case of being used for anesthetics, you wont get that uncomfortable situation where a dentist has to inject you multiple times in multiple places. It also has a much faster uptake. The dermal layer is what protects our body, and our body thus reacts fastest to materials spread into the first line of defense.

Inolife also carries Ino 100 which is a self-injectable that can be used for up to 50 injections per nozzle. It harbours the following characteristics as well:

The COVID-19 pandemic truly proves the importance that remote medicine is going to have in the future.

Partnerships for success

Interest in Inolife has already led to a series of partnerships, joint ventures and endorsements, as the company is searching to make a difference on a global scale. It was joint ventures with pharmaceutical companies that helped develop the key nano-powder described above. These partnerships will allow for a global supply chain to patients across the globe when larger-scale production begins.

Many of those interested in Inolife are major players in global health. For example, Pharmajet, works closely with the World Health Organization (WHO) in adapting needle-free injectors for use in vaccines. The pharmaceutical industry in general has expressed a keen interest in the technology, as it anticipates a future demand for more user-friendly devices and whats more user friendly than dropping needles?

Governments have also taken note. Israel expressed its approval of the technology, and former Mexican President and Legal Representative of Centro Fox, Vincente Fox, was so interested that he became an advisor of the company.

The full press release can be viewed here.

He explains, To Centro Fox and myself, personally, this represents a great opportunity to accomplish our plan of removing the risk of needle stick injuries and cross contamination for care givers, as well as reduce anxiety for patients. Our main driver is to think of patient comfort at the system-level as well as improve home care compliancy. We want to fundamentally change how physicians and patients interact.

He adds, Now that Inolife Sciences has shown a viable and proven business model, we are moving to partner with pharmaceutical companies to enhance their therapeutic applications and compliancy by using Inolifes current technologies. We also look into the very near future and see the positive impact the Inolife nanoparticle powder injection technology could have on the entire injection marketwe can expect a few more partnerships this year and, in the years, to come.

Inolife is also looking to partnerships to perhaps expand beyond the medicines it already envisions. Studies in collaboration with McGill University are looking to develop a cannabidiol injectable to compete with other drugs for chronic pain and inflammation.

Plans for the Future

Wright is organizing private fundraising and is getting ready to take the company into public listing, which is a crucial milestone that investors should keep an eye peeled for. While a lot of focus has been on R&D and partnerships, Wright has expressed his interest in a scalable business, selling not just the injectors but the supply of the disposable syringes and further developed nano-powder injectables.

Clinical testing is also running at full steam on many of their planned products. Inolife was founded with the intention to positively impact peoples wellbeing and it is only warming up to the task. The invention of the hypodermic needle was once a medical breakthrough. One day, however, it may end up in a museum as an outdated relic, only serving as a story to scare our children about how we used to take our medicine.

Learn more about Inolife by visiting their website here.

See how the companys technology works by watching their YouTube video below.

For more investor-related information please email Chris Brown, Global Capital Markets or Michael Wright, CEO, Inolife Sciences.

See more here:
Inolife is going to revolutionize how we take our medicine - BNNBloomberg.ca

Ongoing advancements in cancer research continue to lead to the introduction of newer and better treatment options including drug therapies. The provision of newer drugs and treatments is expected to improve the diagnostic and treatment rate for triple-negative breast cancer.

Some of the recent clinical efforts are being targeted at the molecular level characterization of triple-negative breast cancer across emerging therapeutic targets such as epigenetic proteins, PARP1, androgen receptors, receptor and non-receptor tyrosine kinases, and immune checkpoints.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/14305

Company Profiles

These initiatives are anticipated to boost revenue growth of the triple-negative breast cancer treatment market. In a new research study, Persistence Market Research estimates the globaltriple-negative breast cancer treatment marketrevenue to cross US$ 720 Mn by 2026 from an estimated valuation of just under US$ 505 Mn in 2018. This is indicative of a CAGR of 4.7% during the period 2018 to 2026.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/14305

Development of generics is another key opportunity area in the triple-negative breast cancer treatment market. With the rapidly expanding number of cancer cases across the world, there is a need for effective cancer management, including the provision of better and more efficient drugs.

Developing economies are faced with challenges on several fronts including paucity of funds and lack of proper treatment options, calling for more innovative approaches to affordable healthcare. The availability of biosimilars and affordable generic anti-cancer drugs in developing regions is expected to significantly reduce the burden of cancer care.

A projected cost reduction to the tune of more than 30% 40% and extended use of generic drugs is expected to reduce overall cancer treatment costs, thereby increasing the treatment rate for triple-negative breast cancer. This is further anticipated to create lucrative growth opportunities in the global triple-negative breast cancer treatment market.

Advances in Cancer Treatment and Introduction of Innovative Cancer Treatment Drugs to Boost Revenue Growth of the Triple-Negative Breast Cancer Treatment Market

Breast cancer is one of the most common types of cancer in women, and over the years, pharmaceutical and life sciences companies have been conducting advanced research and development activities to devise newer treatment options and drugs to treat breast cancer.

Several new drug formulations are currently in the pipeline in different stages of clinical development and this is expected to bode well for the triple-negative breast cancer treatment market. Innovation in oncology therapeutics has shifted focus towards an outcome based approach to cancer care, with an increasing emphasis on combination drugs and newer therapeutic modalities.

This is further likely to put the global triple-negative breast cancer treatment market on a positive growth trajectory in the coming years.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/14305

Combination Therapy and Advancements in Nano Medicine Research Trending the Triple-Negative Breast Cancer Treatment Market

One of the biggest trends being observed in the global market for triple-negative breast cancer treatment is the shift towards combination therapy. Companies in the global triple-negative breast cancer treatment market are conducting clinical trials for combination therapies by collaborating with other players in the market.

Combination therapies are the latest innovation in the field of oncology and the combination of therapeutic drugs with chemotherapy is said to be an effective protocol for the treatment of triple-negative breast cancer.

Another huge trend in the triple-negative breast cancer treatment market is the emergence of nanotechnology as an efficient tool in the clinical management of critical diseases such as triple-negative breast cancer. It has been observed that the combination of gold nanoparticles and folic acid results in higher cell entry rate in both in-vitro and in-vivo models, indicative of the fact that folate receptors are effective targeted therapies for the treatment of triple-negative breast cancer.

Nanoparticles facilitate systematic and efficient delivery of drugs and agents to the site of the tumor. Advanced R&D in nanotechnology and nano medicine is one of the top trends likely to impact the global triple-negative breast cancer treatment market in the years to come.

Report Highlights:

Explore Extensive Coverage of PMR`sLife Sciences & Transformational HealthLandscape

Opioids MarketOpioids Market Segmented By Morphine, Codeine, Fentanyl, Meperidine, Methadone Product in Analgesia, Cough Suppression, Diarrhea Suppression.For More Information

Non Infectious Macular Edema Treatment MarketNon-infectious Macular Edema Treatment Market Segmented By Anti-VEGF, Corticosteroids, Immunosuppressant, Biologics Drug with Non-infectious Uveitic Macular Edema, Diabetic Macular Edema, Retinal Vein Occlusion with Macular Edema Indication by Oral, Parenteral, Topical Route of Administration.For More Information

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics andmarket research methodologyto help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMRs collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Ashish KoltePersistence Market ResearchAddress 305 Broadway, 7th FloorNew York City,NY 10007 United StatesU.S. Ph. +1-646-568-7751USA-Canada Toll-free +1 800-961-0353Salessales@persistencemarketresearch.comWebsitehttps://www.persistencemarketresearch.com

Originally posted here:
Research Report Explores The Triple Negative Breast Cancer Treatment Market Will Be Valued At US$ 720 Mn By 2026 - Lake Shore Gazette

The term Nanotechnology is used when the developments occur at very miniscule 0.1 to 100 nm scale.Nanomedicineis an offshoot of Nanotechnology which basically involves development of medicines at a molecular stage. The medicines ae developed for treatment of life threatening diseases such as cancer, Parkinson, Alzheimer, diabetes, etc. These also have various other applications such as diagnosis, prevention and even regeneration of tissues.

The development of a nanomedicine is a tedious process and usually takes several years. These are based on technologies such as quantum dots, nanorobots, nanorods, nanoparticles, fullerenes, liposomes and more. The diagnosis field has more precise and reliable nanotechnology methods. These require minimum biological sample which facilitates considerable reduction in consumption of reagents and disposables. This technology is also widely used in drug delivery purpose due to nanoscale particles.

The Final Report will cover the impact analysis of COVID-19 on this industry.

Download Sample of This Strategic Report:https://www.kennethresearch.com/sample-request-10064965

Market Dynamics

A number of factors drive the market for Nanomedicine. The improvement in regulatory framework, the technology becoming more familiar, heavy funding and a positive mindset by the governments of various countries help its cause. Apart from these, a continuous increase in the aforementioned chronic diseases has been observed. Thus, there has been a phenomenal rise in the demand of nanomedicines. With new companies stated to enter the market, the supply-demand gap of nanomedicines will be bridged to a larger extent. There are debates on the toxicity of these medicines and the high cost associated to it but currently, the benefits outweigh the riskinvolved.

Market Segmentation

The basis of segmentation of this market is applications in medicines, targeted disease and geography. The application segment includes, drug delivery, drugs, biomaterials, active implant, in-vitro diagnostic, and in-vivo imaging where drug delivery contributes higher than rest followed by in-vitro diagnostics. It is divided on the basis of diseases in the following segments: neurology, cardiovascular, oncology, anti-inflammatory, anti-infective and others. Till 2012, the market was heavily dominated by oncology segment however currently, the cardiovascular nanomedicine market is the fastest growing.

Request For Sample Request:https://www.kennethresearch.com/sample-request-10064965

Regional/Geographic Analysis

The market was heavily dominated by the US but there has been a rise in the Asia Pacific region and is expected to grow faster owing to a rapid increase in geriatric population and rising awareness of healthcare. Even Europe is stated to grow faster than the US due to its extensive product pipeline portfolio and improving regulatory frameworks.

Key Players

Some of the major players in the market includeGE Healthcare, Abbott Laboratories,Sigma-Tau Pharmaceuticals, Inc., Johnson & Johnson, Mallinckrodt plc, Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., Celgene Corporation, Teva Pharmaceutical Industries Ltd.About Kenneth Research

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation

Contact Us

Kenneth Research

Email : [emailprotected]

Phone: +1 313 462 0609

Read the rest here:
Healthcare Nanotechnology (Nanomedicine) Market is Anticipated to Register a Significant CAGR over a Forecast Period 2016-2022 - Germany English News

The market research study titled Global Nanomedicine Market Size, Status and Forecast 2020-2026 brings you the most recent and the most updated data on the market. The report provides extensively researched information about the global Nanomedicine market structure, valuates, and outlines its variable aspects and applications. The report comprehensively represents the context of current and future trends driving the profit matrix. The report contains computable information, qualitative information sets, and evaluation tools. The research highlights major market insights, challenges, current trends, and value chain analysis.

The study provides estimates on global Nanomedicine market share, market size, and regional topography along with statistics, diagrams and charts explaining the differing interesting framework of the industry landscape. Divided by product type, applications, industry verticals, and research regions, the report research document delivers an explanation of the perspectives and comprehensive market statistics. It further covers the pricing of the product, production and consumption volume, cost analysis, industry value, barriers and growth drivers, major market players, demand and supply ratio of the market, the growth rate of the market and forecast from 2020 to 2026. Top players are completely profiled in this report.

DOWNLOAD FREE SAMPLE REPORT: https://www.magnifierresearch.com/report-detail/28942/request-sample

The major manufacturers covered in this report: Combimatrix, Ablynx, Abraxis Bioscience, Celgene, Mallinckrodt, Arrowhead Research, GE Healthcare, Merck, Pfizer, Nanosphere, Epeius Biotechnologies, Cytimmune Sciences, Nanospectra Biosciences,

Regional Analysis For Market:

North America (United States, Canada, Mexico), Asia-Pacific (China, Japan, South Korea, India, Australia, Indonesia, Thailand, Malaysia, Philippines, Vietnam), Europe (Germany, France, UK, Italy, Russia, Rest of Europe), Central & South America (Brazil, Rest of South America), Middle East & Africa (GCC Countries, Turkey, Egypt, South Africa, Rest of Middle East & Africa) are leading countries and provide data like market share (%), sales (volume), imports & exports by types and applications, analysis, production, consumption, and consumption forecast. Information about different regions helps the reader to understand the global Nanomedicine market better.

Product type coverage (market size & forecast, a major company of product type etc.):

Application coverage (market size & forecast, different demand market by region, main consumer profile etc.): Segmentation encompasses oncology, Infectious diseases, Cardiology, Orthopedics, Other

Moreover, the report has included the leading merchants in this global Nanomedicine market everywhere throughout the world. In this part, market depictions, requirements, and product portrayals, manufacture, competence, contact figures, cost, and revenue are determined. Additionally, upstream raw materials and downstream demand studies are administered. It also includes investment strategies, marketing strategies, and product development plans adopted by major players of the market. The report further incorporates speculation attainability investigation and venture return investigation.

ACCESS FULL REPORT: https://www.magnifierresearch.com/report/global-nanomedicine-market-size-status-and-forecast-2020-2026-28942.html

Some of The Points Explained in The TOC of Market Report:

Customization of the Report:This report can be customized to meet the clients requirements. Please connect with our sales team ([emailprotected]), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

Magnifier Research is a leading market intelligence company that sells reports of top publishers in the technology industry. Our extensive research reports cover detailed market assessments that include major technological improvements in the industry. Magnifier Research also specializes in analyzing hi-tech systems and current processing systems in its expertise. We have a team of experts that compile precise research reports and actively advise top companies to improve their existing processes. Our experts have extensive experience in the topics that they cover. Magnifier Research provides you the full spectrum of services related to market research, and corroborate with the clients to increase the revenue stream, and address process gaps.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: [emailprotected]Web: http://www.magnifierresearch.com

See the original post here:
Global Nanomedicine Market by Type, Application, Element, & by Region Trends and Forecast to 2026 - Jewish Life News

PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Regulatory News:

NANOBIOTIX (Paris:NANO) (Euronext: NANO - ISIN: FR0011341205 the Company), a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced that the protocol for the first trial from its clinical collaboration with The University of Texas MD Anderson Cancer Center (MD Anderson) has been designated as safe to proceed by the US Food and Drug Administration (FDA). The trial was co-developed with Nanobiotix and MD Anderson is the sponsor and executor of the trial.

The investigational new drug application (IND), covers a phase I study evaluating the safety and feasibility of NBTXR3 activated by radiation therapy for patients with locally advanced (LAPC) or borderline resectable (BRPC) cases of pancreatic ductal adenocarcinoma (PDAC). This trial is the first to evaluate NBTXR3 activated by radiation therapy in pancreatic cancer.

Significant Unmet Needs and Opportunity in Pancreatic Cancer

Pancreatic cancer is a rare, deadly disease. Given that surgery with R0 resection (i.e. macroscopically complete tumor removal with negative microscopic surgical margins) remains the only hope for long-term survival, clinical trials have investigated various neoadjuvant strategieswherein patients receive anti-cancer drugs or radiation prior to surgeryto increase the surgery-eligible population while also increasing the R0 resection rate.

In support of the rationale for neoadjuvant therapy, a retrospective analysis demonstrated a near doubling in overall survival (OS) in PDAC patients who underwent surgery, which was attributed, at least in part, to the increased proportion of BRPC patients who became eligible for surgery as a result of neoadjuvant intervention. Importantly, there are also select cases of LAPC patients being considered for surgical resection based on their response to therapy. Given the poor prognosis of PDAC, therapeutic regimens able to increase the proportion of BRPC and LAPC patients eligible for surgery could improve survival outcomes in this population with unmet need.

A Phase I Study Evaluating NBTXR3 Activated by Radiation Therapy in Patients with PADC

The MD Anderson trial is an open-label, single-arm, prospective phase I study consisting of two parts: (i) dose-escalation to determine the recommended phase 2 dose (RP2D); and (ii) expansion at RP2D.

The patient population will include adults (age 18 years) with BRPC or LAPC that are radiographically non-metastatic at screening, and that have not previously received radiation therapy or surgery for pancreatic cancer. The number of participants enrolled will be determined based on the maximum number required to establish the RP2D. Up to 24 subjects will be enrolled, including a maximum of 12 subjects with LAPC for the dose-finding part. Twelve additional subjects with either LAPC or BRPC will be enrolled for the RP2D expansion. The planned enrollment period is 18 months. The first patient should be injected the summer of 2020.

The objectives of the study are the determination of dose-limiting toxicity (DLT), the maximum tolerated dose (MTD), and the RP2D.

About NBTXR3

NBTXR3 is a first-in-class product designed to destroy tumors through physical cell death when activated by radiotherapy. NBTXR3 has a high degree of biocompatibility, requires one single administration before the first radiotherapy treatment session, and has the ability to fit into current worldwide radiation therapy standards of care. The physical mode of action of NBTXR3 makes it applicable across solid tumors such as lung, prostate, liver, glioblastoma, pancreas, and breast cancers.

NBTXR3 is actively being evaluated in locally advanced head and neck squamous cell carcinoma (HNSCC) of the oral cavity or oropharynx in elderly and frail patients unable to receive chemotherapy or cetuximab with limited therapeutic options. Promising results have been observed in the phase I trial regarding local control. In the United States, the company has started the regulatory IND process to commence a phase III clinical trial in locally advanced head and neck cancers.

Nanobiotix is also running an Immuno-Oncology development program. Pursuant to an effective IND, the Company has launched a clinical trial of NBTXR3 activated by radiotherapy in combination with anti-PD-1 antibodies in locoregional recurrent (LRR) or recurrent and metastatic (R/M) HNSCC amenable to re-irradiation of the HN and lung or liver metastases (mets) from any primary cancer eligible for anti-PD-1.

The other ongoing NBTXR3 trials are treating patients with hepatocellular carcinoma (HCC) or liver metastases, locally advanced or unresectable rectal cancer in combination with chemotherapy, head and neck cancer in combination with concurrent chemotherapy, and prostate adenocarcinoma. The company has a large-scale, comprehensive clinical research collaboration with The University of Texas MD Anderson Cancer Center (9 new phase I/II clinical trials in the United States) to evaluate NBTXR3 across head and neck, pancreatic, lung, gastrointestinal and advanced cancers.

About NANOBIOTIX: http://www.nanobiotix.com

Incorporated in 2003, Nanobiotix is a leading, clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell.

The Nanobiotix philosophy is rooted in designing pioneering, physical-based approaches to bring highly effective and generalized solutions to address unmet medical needs and challenges.

Nanobiotixs first-in-class, proprietary lead technology, NBTXR3, aims to expand radiotherapy benefits for millions of cancer patients. Nanobiotixs Immuno-Oncology program has the potential to bring a new dimension to cancer immunotherapies.

Nanobiotix is listed on the regulated market of Euronext in Paris (Euronext: NANO / ISIN: FR0011341205; Bloomberg: NANO: FP). The Companys headquarters are in Paris, France, with a US affiliate in Cambridge, MA, and European affiliates in France, Spain and Germany.

Disclaimer

This press release contains certain forward-looking statements concerning Nanobiotix and its business, including its prospects and product candidate development. Such forward-looking statements are based on assumptions that Nanobiotix considers to be reasonable. However, there can be no assurance that the estimates contained in such forward-looking statements will be verified, which estimates are subject to numerous risks including the risks set forth in the reference document of Nanobiotix registered with the French Financial Markets Authority (Autorit des Marchs Financiers) under number R.19-018 on April 30, 2019 (a copy of which is available on http://www.nanobiotix.com) and to the development of economic conditions, financial markets and the markets in which Nanobiotix operates. The forward-looking statements contained in this press release are also subject to risks not yet known to Nanobiotix or not currently considered material by Nanobiotix. The occurrence of all or part of such risks could cause actual results, financial conditions, performance or achievements of Nanobiotix to be materially different from such forward-looking statements.

See the article here:
NANOBIOTIX Announces First Phase I Trial With NBTXR3 in Pancreatic Cancer Is Safe to Proceed Per US FDA - Business Wire

CAMBRIDGE, Mass., April 23, 2020 /PRNewswire/ -- Dream of dining and discussing space travel withformer NASA astronautand MITAerospace Engineering Professor,Jeffrey Hoffman? Want to grab a sandwich and talk sports analytics withBen Shields,former ESPN executive and Senior Lecturer at MIT Sloan?Perhaps you'd like to break bread and ponder the future of nanomedicine withPaula Hammond, the head of MIT's Department of Chemical Engineering?

Now is your chance. Agrassroots organizationof MIT staff and faculty members have launched acharity auctionoffering participants the opportunity to bid on lunches with over 50 luminaries at MIT. In addition, the group is runninga rafflewhereparticipants can contribute $5 to be entered into a drawing to win a lunch with the MIT faculty member of their choice from the auction.

The proceeds from the fundraiser will be disbursed to theCambridge Community Foundation's Cambridge COVID-19 Emergency Fundand theCambridge Mayor's Disaster Relief Fund for COVID-19with the help ofCommunity Giving at MIT.

As the global pandemic has erupted over the last month, MIT has worked to help the City of Cambridge weather the ongoing public health emergency. The Institute's assistance has included direct financial support, suspension of rent for tenants in MIT-owned properties, housing for emergency responders in unused MIT buildings, and other initiatives.

"I share with my colleagues a feeling of responsibility to help supportthose who've been affected by the current health crisis here in our home city of Cambridge," saysDavid V. Capodilupo, Assistant Dean ofMIT Sloan Global Programs."This is one smalland we hopefun and interestingway for us to give back to our local community during this challenging period."

Bidding for the fundraiser, which is modeled after Warren Buffett's annual charity auction, launched on April 16thandwill conclude on April 30th at 11:55pm. Winning bidders can choose between a conversation with their chosen faculty member via Zoom or an in-person lunch to take place after social distancing measures are eased.

"At a time of lockdowns and social distancing, this fundraiser can help build new and meaningful connections," says Longzhen Han, Assistant Director of theMIT Regional Entrepreneurship Acceleration Program,who is spearheading the fundraiser. "Not only does MIT have brilliant faculty members, they are also very generous. We are thrilled that they are dedicating their time in this unique way to benefit a good cause close to home."

The auction website showcases the nearly 60 professors from over 10 different departments who have signed on to the effort. Each bio includes a fun factconsider it a conversation starterabout the faculty member.For instance,Jeffrey C. Grossman, the Department Head of Materials Science and Engineering, used to be a competitive ballroom dancer.Zeynep Ton, Professor of the Practice of Operations Management at MIT Sloan, played volleyball for Penn State and participated in two NCAA final four tournaments. MeanwhileRoberto Rigobon, Professor of Applied Economics at the school, once played in a rock band that had three number one hit songs in Venezuela.

Rene Richardson Gosline, a Senior Lecturer in the Management Science group at MIT Sloan, says she was inspired to join the effort because, "Instead of shuffling the deck, COVID-19 may calcify structural inequality and hit the vulnerable hardest. We must all do our part. At MIT, we say, "Of the world. In the world. For the world.' The #mitcharitylunches embody this ethos."

All donations to the auction are tax deductible. The organizers say they are open to engaging with local donor organizations interested in making matching gifts or providing other support.

"Our greatest weapon is the strength of our community," saysSharmila C. Chatterjee, Senior Lecturer in Marketing and the Academic Head for the MBA Track in Enterprise Management at MIT Sloan."We do well when every single member does well. Working together, as one, is the only way to make this happen."

For more information, clickhere.

About the MIT Sloan School of ManagementThe MIT Sloan School of Management is where smart, independent leaders come together to solve problems, create new organizations, and improve the world. Learn more at mitsloan.mit.edu

For further information, contact:

Paul Denning

or

Patricia Favreau

Director of Media Relations

Associate Director of Media Relations

617-253-0576

617-253-3492

[emailprotected]

[emailprotected]

SOURCE MIT Sloan School of Management

http://www.mitsloan.mit.edu

Originally posted here:
Dine with an MIT luminary for a good cause: Flash charity auction offers the opportunity to bid on lunch with MIT professors in support of COVID-19...

As the coronavirus overwhelms many parts of the world, fake treatments continue to spread throughout the internet.

Bogus claims have prompted the US Food and Drug Administration to take action against several individuals and companies, including prominent social media influencer Alex Jones of the site Infowars. The agency recently issued a warning letter to the conspiracy theorist demanding he stop promoting products he sells on his website as cures for the deadlyvirus.

The FDA cited several examples of Jones fake claims that date back to February. The letter stated,Described below, you sell products that are intended to mitigate, prevent, treat, diagnose, or cure COVID-19 in people. We request that you take immediate action to cease the sale of such unapproved and unauthorized products for the mitigation, prevention, treatment, diagnosis, or cure of COVID-19.

In one video posted on March 10, Jones claimed that "the patented Nano Silver we have, the Pentagon has come out and documented, and Homeland Security have said this stuff kills the whole SARS corona family, at point blank range.

In a subsequent broadcast, Jones advised listeners to boost your immune system, adding, We have the products that are documented on record to be good for your body, before promoting gels and toothpaste that he claims contain silver. The FDA has previously warned that colloidal silver is not safe or effective for treating any disease or condition.

Prior to the warning from the FDA, New York Attorney General Letitia James sent a cease-and-desist letter in March demanding Jones stop promoting his bogus medicine.

US Attorney General William Barr directed US attorneys' offices in every state to make enforcement a priority, and states' attorneys general are handing companies cease-and-desist letters demanding they stop misleading the public.

California Attorney General Xavier Becerra issued a consumer alert that warned the public,Do not be hustled by opportunistic tricksters claiming to have a miracle cure. There is not a cure for COVID-19...I encourage anyone who has been the victim of a snake oil scam or who otherwise has information about products that are falsely touted as coronavirus treatments, tests, or cures to immediately file a complaint through my offices website.

Last month, the Missouri Attorney General sued prominent televangelist Jim Bakker and his company, Morningside Church Productions Inc., for claiming on a broadcast featuring a naturopathic doctor, that the product Silver Solution can cure coronavirus. This led to a joint warning letter from the FDA and FTC.

In the past few weeks, the FDA and FTC issued several more warning letters to companies claiming their products prevent, treat or cure coronavirus. This follows several other warning letters jointly issued by the agencies in early March.

A recent press release stated that The FDA considers the sale and promotion of fraudulent COVID-19 products to be a threat to the public health. We have an aggressive surveillance program that routinely monitors online sources for health fraud products, especially during a significant public health issue such as this one, said FDA Commissioner Dr. Stephen M. Hahn.We understand consumers are concerned about the spread of COVID-19 and urge them to talk to their health care providers, as well as follow advice from other federal agencies about how to prevent the spread of this illness. We will continue to aggressively pursue those that place the public health at risk and hold bad actors accountable.

FTC Chairman Joe Simons added that there is already a high level of anxiety right now. What we dont need in this situation are companies preying on consumers by promoting products with fraudulent prevention and treatment claims. These warning letters are just the first step. Were prepared to take enforcement actions against companies that continue to market this type of scam.

Last month, the FDA and FTC jointly issued warning letters to Vital Silver, Quinessence Aromatherapy Ltd., Xephyr, LLC (who does business as N-Ergetics), GuruNanda, LLC, Vivify Holistic Clinic, Herbal Amy LLC, and The Jim Bakker Show for hawking teas, essential oils, tinctures and colloidal silver making coronavirus claims.

Several dietary supplement industry trade associations are also urging retailers to not stock products that make coronavirus claims.

The American Herbal Products Association, the Consumer Healthcare Products Association, the Council for Responsible Nutrition and the United Natural Products Alliance recently issued a press release applauding the FDA forcalling out marketers who make illegal and unsubstantiated drug claims related to COVID-19.

The statement noted that the trade associationssupport the responsible sale and use of vitamins, minerals, herbs and other dietary supplements that provide many positive benefits promoting better health and wellness. As we face the unprecedented threat of this global pandemic, illegal and unsubstantiated drug claims misdirect consumers toward ineffective products, divert them from seeking critical medical care, and endanger the public health.

There are currently no products on the market that are approved to treat or prevent coronavirus. While there are investigational COVID-19 vaccines and treatments under development, these have not been fully tested for safety or effectiveness. Even if there was an ingredient that could treat or prevent the virus, dietary supplement companies are banned by DSHEA from making any disease treatment claims.

Read more from the original source:
Cashing in on the crisis: More FDA warning letters - NutraIngredients-usa.com

Global Nano Therapy Market was valued US$ XX Mn in 2019 and is expected to reach US$ XX Mn by 2027, at a CAGR of 8.6% during a forecast period.

Global Nano Therapy Market

Market Dynamics

Nanotechnology is the manipulation of matter on an atomic, molecular, and supramolecular scale. Nanotherapy is a branch of Nano medicine that includes using nanoparticles to deliver a drug to a given target location in the body so as to treat the disease through a process called as targeting.

This report provides insights into the factors that are driving and restraining the global Nano Therapy market. Nanotherapy is also referred to as targeted therapy, which offers to transport the molecules to the affected cells to treat the disease without affecting other negative effects on the healthy cells. Nanoparticles allow for multiple functional groups to be added to the surface. Each of the functional groups contributes to the effectiveness of this method of therapy and deliver its components in a controlled way once it gets to the target cells/tissue. Nano therapy is considered as recent technology for some diseases, which are implemented with the help of submicron-sized molecular devices or nanoparticles. Nanoparticles can improve the drug accessibility in the body with strength, drag out the medication, and can upsurge the half-life of plasma and boost the drug specificity. These are the factors driving the growth of the Nano therapy market.

REQUEST FOR FREE SAMPLE REPORT: https://www.maximizemarketresearch.com/request-sample/54507

As compared to the conventional methods, this method has increased more popularity owing to its high accuracy when it comes to administering therapeutic formulations. The market is thriving, with around 250 Nano-medical products being verified or used for humans. Though, with Nano therapy, the carrier is protected from degradations, which allows it to reach given target cells in the body for a local reaction. Nano therapy is considerably used in the treatment of diseases like cancer, diabetes, and cardiovascular diseases. A recent study by the Journal of Diabetes and Metabolic diseases has stated that the incidence of MS ranged from 30.5 to 31.5% in China and 35.8 to 45.3% in India.

However, an absence of controlling standards in the examination of Nano therapy and high expenditure of treatment are several of the major factors that are restraining the growth of the Nano therapy market during the forecast period.

Global Nano Therapy Market Segment analysis

Based on Type, the Nanomaterial segment is anticipated to grow at a CAGR of 20.8% during the forecast period. The nanomaterial is the materials with at least one exterior dimension in the size range of nearly 1 to 100 nanometers. The nanomaterial is intended for developing novel characteristics and has the potential to improve quality of life. The nanomaterial is generally used in cosmetics, healthcare, electronics, and other areas currently. Unceasing development and innovation in the field are impelling the growth of the global nanomaterials market. The amazing chemical and physical properties of materials at the nanometer scale allow novel applications. For instance, energy conservation and structural strength improvement to antimicrobial properties and self-cleaning surfaces. Nanotechnology is being increasingly efficient by spending mainly on R&D activities which are resulting in the development of current technologies and innovations with reference to the new materials.

Global Nano Therapy Market Regional analysis

North America region dominated the Nano therapy market with US$ XX Mn in 2019. The availability of technology, increasing healthcare spending, and government funding for research and development are some of the factors boosting the growth of the Nano therapy market in the region. Europe is expected to follow the Americas and bring in the second leading market share for Nano therapy throughout the forecast period. Europe is mainly driven by awareness and improvement in the nanotechnology sector.

Recent Developments

In 08 May 2019- Cisplatin cis-(diammine) dichloridoplatinum (II) (CDDP) is the first platinum based complex approved by the food and drug administration (FDA) of the United States (US). Cisplatin is the first line chemotherapeutic agent used alone or combined with radiations or other anti-cancer agents for a broad range of cancers such as lung, head and neck.

In May 2019- A new study conducted by scientists from the Indian Institute of Technology, Bombay, have designed hybrid nanoparticles to treat cancer. These nanoparticles are made from gold and lipids. These nanoparticles respond to light and can be directed inside the body to release drugs to a targeted area, and are biocompatible, meaning theyre not toxic to a human body.

In September 2019, researchers at Finlands University of Helsinki, in partnership with the bo Akademi University and Chinas Huazhong University of Science and Technology developed an anti-cancer nanomedicine useful for targeted cancer chemotherapy.

The objective of the report is to present a comprehensive analysis of the Global Nano Therapy Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.The report also helps in understanding Global Nano Therapy Market dynamics, structure by analyzing the market segments and project the Global Nano Therapy Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Nano Therapy Market make the report investors guide.Scope of the Global Nano Therapy Market

DO INQUIRY BEFORE PURCHASING REPORT HERE: https://www.maximizemarketresearch.com/inquiry-before-buying/54507

Global Nano Therapy Market, By Type

Nanomaterial and Biological Device Nano Electronic Biosensor Molecular Nanotechnology Implantable Cardioverter-DefibrillatorsGlobal Nano Therapy Market, By Application

Cardiovascular Disease Cancer Therapy Diabetes Treatment Rheumatoid ArthritisGlobal Nano Therapy Market, By Regions

North America Europe Asia-Pacific South America Middle East and Africa (MEA)Key Players operating the Global Nano Therapy Market

Selecta Biosciences Inc. Cristal Therapeutics Sirnaomics Inc. Nanobiotix Luna CytImmune Science Inc. NanoBio Corporation Nanospectra Biosciences Inc. Nanoprobes Inc. NanoBioMagnetics.n.nu Smith and Nephew NanoMedia Solutions Inc. Nanosphere Inc. DIM Parvus Therapeutics Tarveda Therapeutics

MAJOR TOC OF THE REPORT

Chapter One: Nano Therapy Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three: Global Nano Therapy Market Competition, by Players

Chapter Four: Global Nano Therapy Market Size by Regions

Chapter Five: North America Nano Therapy Revenue by Countries

Chapter Six: Europe Nano Therapy Revenue by Countries

Chapter Seven: Asia-Pacific Nano Therapy Revenue by Countries

Chapter Eight: South America Nano Therapy Revenue by Countries

Chapter Nine: Middle East and Africa Revenue Nano Therapy by Countries

Chapter Ten: Global Nano Therapy Market Segment by Type

Chapter Eleven: Global Nano Therapy Market Segment by Application

Chapter Twelve: Global Nano Therapy Market Size Forecast (2019-2026)

Browse Full Report with Facts and Figures of Nano Therapy Market Report at: https://www.maximizemarketresearch.com/market-report/global-nano-therapy-market/54507/

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Lumawant Godage

Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Contact: +919607065656/ +919607195908

Website: http://www.maximizemarketresearch.com

Read more:
Global Nano Therapy Market- Industry Analysis and Forecast (2020-2027) - Publicist360

Reusable respirator masks could be a lifeline for health careworkerstrying toprotect themselveswhiletreatingcoronavirus patients.

Theyprovidethesamelevel ofprotection as disposableN95 respirators,which arein short supply around theworld.Theycan beeasily disinfected between patients and shifts. And theylast for months.

But thenationsemergency supply of medicalequipment never stocked them,despiteyears of research predicting direshortfalls of disposablerespirators during a pandemic andrecommendations to stockpilereusableones.

Thedecision not to buy them for the Strategic National Stockpileis inexplicabletoTomFrieden,who led theU.S.Centers forDiseaseControland Preventionuntil 2017.

You can get oneto a health careworker and say,Here's how you clean it and it's yours for theduration of thepandemic, Friedentold USA TODAY. And thoseareon themarket."

Hesaid theCDC predicted as many as 4 billion disposablemasks would beneededin anemergency liketheonethecountry faces now.

An official at theDepartment of Health and Human Services, which oversees thestockpile,said not buying thereusablerespirators was a matter of balancing funding and priorities.

The stockpile hasan alternativeto disposable masks,the official said: battery-powered, air-purifyingmasks.Butthe official,who declined to be identified without authorization,declined to say how many of those are in stock.

Thosedevices, which blow air into the users faces, can becomplicated, noisy and costly.Theyrun$500to $800apiecemany timesmore thana reusable respirator,according to astudyby researchers at the U.S. Department of Veterans Affairspublished in 2015.

Reusablerespirators costbetween$25 and $50;the disposable ones are 25to65 centseach.

In addition to disposable masks, that study recommended stockpiling reusablerespiratorsover air-purifying devices because they cost less and are easier touse.

Officials running thenational stockpileshould havebought reusablerespirators,said Lisa Pompeii, a researcherat Baylor Collegeof Medicine.

Pompeiiis theleadauthor of a study published last week that concluded health careworkers could bequickly fittedfor reusablerespirators and trained on how to usethem.

Theneed is moreurgent thanever.Almost 20% of health careproviders surveyed a weekagohadnorespirators.Another 28% said they werealmost out, according totheAssociation for Professionals in Infection Control andEpidemiology.

Its so discouraging,thesituation wefind ourselves in,said Ann MariePettis, theassociations president-elect.Wereout theretrying to help thosewho aretruly on thefront lines to help them besafeand keep their families safe.

But "so much of what wenormally teach is having to bethrown out thewindow becauseof thelack of supplies, shesaid. Theres all theseweird things weretelling peoplethey can do, suchasreusing disposablemasks.

TheJoint Commission, which accredits hospitals nationwide,altereditspolicyon protectiveequipmentTuesday to allowtheuseof homemademasksan extrememeasureto betaken onlywhenstandardequipmentis unavailable.

Thedeath toll from coronavirus topped 9,600 in the United States on Saturday,with thenumber of confirmed cases rising to337,000, according to Johns Hopkins University.Worldwide, thevirus haskilled more than 70,000 peopleand sickenedmorethan 1.2 million.

Reusable respirators vs. disposable face masks

Reusablerespiratorsarewidely used in manufacturing andotherindustriesto prevent users from inhaling harmful particles, such as thosefromasbestos.Millions of Americans havethemin their garages and on their workbenches.

Researchers specializing in respiratory protection have foundreusablerespirators,known as elastomerics,arealsoeffectivein health care settingsbecause theyofferthe same protectionas a disposable N95 respirator mask.

Thelogistics aremorecomplicated with thereusable, but thebenefits arethat wevegot protection, and you dont haveto worry about it running out, Pompeii, theBaylor researcher, said.

Themasksarefitted for size, just likethedisposablemasks,toensurea properseal.Theycan bewiped down with hospital-gradedisinfectant wipes between patientsand fully sanitized between shifts. They havecartridges thattrapparticles in theair, includingnano-sized ones, saidStella Hines,a professor and researcher at theUniversity of Maryland School of Medicine.

Thevirus at somepoint will dieon thefilterwerenotexactly surehow long, but within days, saidHines, whohas co-authoredseveralstudies on theuseofelastomeric respiratory masks in health care.

"And then as long as that filter doesnt get damaged by being wet,you should beableto usethat filter for a prolongedperiod of time, shesaid.Oneguidelinesays filters can bechangedevery threemonths, shesaid.

Hines is familiar with the respiratorsnot just through herresearch, but becauseemployees at theUniversity of Maryland Medical Centerusethem.

At thebeginningoftheirshifts,workers sign out masks in their size. Theycleanthemwith hospital-gradedisinfectant wipes between patients. At theend of their shifts, therespiratorsaresanitized, saidJim Chang, director of safety andenvironmental health at themedical center.

Theyrewashed, basically, hesaid.Theyredisinfected, dried, packaged, brought back up to thepoint of distribution and theyregood to go for thenext go-around.

The medical center used reusable masks during the 2009 H1N1 pandemic, Chang said, and learned a lot about how to makethem work. Now, weveput all thoselessons back in use.

Health care industry hasn't adopted reusable respirators

Butelastomericshavenot been widely adopted in thehealth careindustry.According to somestudies,workers saytheyrenot as comfortableas disposablemasks andpatients find themscary-looking. In somecases, workers found itmoredifficultto communicatewith patients.

Pompeiinoted that manufacturers havemodified therespirators to makeiteasier tospeak when wearing them.The masks aremadein colors likepurplish pink.

But thelack of widespread usemay havehampered their inclusion in theStrategic National Stockpile.

KerriWizner, anepidemiologistwithMDGuidelinesand lead author of a 2016 studyexaminingrespiratory protectivedevices andemergency preparedness, said themakeup of any medical stockpileshould reflect whats in use.

They want to stock thethings peopleareusing in hospitals, sotheyrenotgoing, 'Usethis thing thats great, but nobodysever used it,Wiznersaid.Inanemergency situationlikewerehaving rightnow, youdont havetheluxury of setting up this fancy program.

Shortages of masks, ventilators needed to treat coronavirus patients

Officialsacross thecountryareventing aboutshortagesof disposablemasks, ventilators and otherequipmentand spiraling pricesas theycompeteagainst oneanother to buy them.

Its thewild, wild west of personal protectiveequipment, Jared Moskowitz, Floridasemergency management director,said Thursday.

Thestateplaced ordersfordisposablerespiratorsmorethan a monthago, hesaid,buthasntbeen told whenthey will arrive.He's now pleadingwith3M,oneof themanufacturers,to selldirectlyto thestaterather than through a distributor.

Nobody really understands who has product, wheretheproduct is or who represents who, hesaid. Frustration is not theword I would use, but theword I would use,you cant print.

Butat theUniversity of MarylandMedical Center, they facenosuchshortage of respirators.

Themedical centerstockpiledelastomericrespiratorsbefore the H1N1 pandemic in 2009.They wereused regularly fora number ofyears beforethey wereput back in storagefor anemergency,Changsaid. Heserved on a National Academies of Sciences,Engineering, and Medicinepanelin 2017 studying theuseofelastomeric respirators in health care, includingsurgesituations.

Themedical centerordered morewhen COVID-19started to spread across China.When the virus struck the United States, workers were fitted and they were passed out toemployees,Chang said.

Chang saidleadership is key when making decisions about how to preparefor a pandemic likethis.

It becomes incumbent upon peoplelikemyself, otheremergency managers, other safety officers,to then sell it to theinstitutions leadership team, that hey, this is a real problem, weneed to beprepared, and this is what you need to do to beprepared.

Read the original:
Reusable respirators protect doctors and nurses against coronavirus, they aren't in the national stockpile - MetroWest Daily News

LONDON, April 6, 2020 /PRNewswire/ -- Brookstreet Equity Partners (Brookstreet), a London-based PEVC investor, is joining the fight against Coronavirus (COVID-19) with the support of its technology portfolio assets in Greece, including Terracom software, Gizelis Robotics and NanoPhos nano-tech.

Terracom, of Ioannina, took the initiative to offer their QR-Patrol & MyLoneWorkers workforce management solutions for free for the remaining of the year to all healthcare institutions worldwide. Terracom is a global technology firm that has developed the renowned QR-Patrol and MyLoneWorkers integrated, cloud-based, software-as-a-service (SaaS) workforce management platforms. The company is entrusted by clients in 82 countries, including Heathrow Airport, GS4, Brinks, Securitas, Carnegie Mellon, Hilton, and IKEA. They believe hospitals can leverage their solutions to manage their workforce more effectively, save time and resources, and channel efforts where they matter most, saving lives.

https://www.terracom.gr/en/covid19

Gizelis Robotics, of Schimatiri, an Industry 4.0 and artificial intelligence integrator, is designing and preparing for production an ultraviolet (UV) disinfection robot for hospitals and factories. Robots are particularly relevant during the Coronavirus outbreak to help manufacturers, small and large, to retain their production. The company's products and services range from full factory automation to small batch processing, for example using robots in hospitals to deliver medicine, in supermarkets for palletising and in factories for welding and handling.

https://grobotics.eu

NanoPhos, of Lavrio, is an innovative, award-winning "smart" coatings manufacturer. They offer a range of diversified nano-technology solutions in energy, marine and construction industries. The company is producing Energy Boosting coatings which can increase the capacity of photovoltaics by up to 8%, thereby helping the electricity grids and supplies shipping firms with friction-reducing nano-coatings worldwide. Latterly, NanoPhos is supporting the Greek market by using part of its production capacity for nano-enhanced health sanitisers.

https://nanophos.com/eng/

Brookstreet's Managing Partner, Omiros D. Sarikas, commented,"Our CEOs and their teams are working tirelessly on initiatives and innovative solutions that will help us win the fight against Coronavirus ... we are all in this together and every day we try to do more for our communities and customers."

About:Brookstreet invests in high-growth, export-driven, innovative small-cap outperformers. Its differentiated strategy focuses on providing private capital, together with day-to-day commercial support and an international platform. The fund manager pioneers the development of the UK's best-in-class private equity model in asymmetric markets. Brookstreet has received numerous awards including being recognised as a Real Deals DraxFuture40 investor that helps shape the future of Europe.

Registered and Regulated by the Financial Conduct Authority (FCA) Member of the British Private Equity and Venture Capital Association (BVCA)

Press:For interviews with Brookstreet and any inquiries with Terracom, Gizelis Robotics or NanoPhos please contact Davinia Smith, T: +44 (0) 207 129 1235, E: dsmith@brookstreetequity.com

Brookstreet Equity Partners LLP42 Brook StreetMayfair, London W1K 5DB,UKPhone: +44 (0) 207 129 1235Website: http://www.brookstreetequity.com Email: info@brookstreetequity.com

View original content:http://www.prnewswire.com/news-releases/london-based-brookstreet-equity-and-its-greek-tech-investments-are-fighting-coronavirus-301035403.html

SOURCE Brookstreet Equity Partners

See the rest here:
London-based Brookstreet Equity and Its Greek Tech Investments Are Fighting Coronavirus - Yahoo Finance

The Global Nano-SiO2 Market report focuses on market size, status and forecast 2020-2027, along with this, report also focuses on market opportunities and treats, risk analysis, strategic and tactical decision-making and evaluating the market. The Nano-SiO2 market report provides data and information on changing investment structure, technological advancements, market trends and developments, capacities, and detail information about the key players of the global Maarket_Keyword market. In addition to this, report also involves development of the Nano-SiO2 market in major region across the world.

Key Players for Global Nano-SiO2 Market:

The global Nano-SiO2 market report profiles major key players of the market on the basis of business strategies, financial weaknesses and strengths and recent development.

PPGAkzonobelSherwin-WilliamsRPM InternationalAxaltaBASFKansai PaintNanomechEIKOSTelsa Nano CoatingsInframat CorporationNanophaseDiamon-Fusion InternationalNanovere Technologies

Get Free Sample PDF (including full TOC, Tables and Figures) of Nano-SiO2 Market @ https://www.apexmarketreports.com/Heavy-Industry/global-nano-sio2-market-by-product-type-dry-322371#sample

The Nano-SiO2 market report also states demand and supply figures, revenue, production, import/export consumption as well as future strategies, sales volume, gross margins, technological developments, cost and growth rate. The Global Nano-SiO2 Market report also delivers historical data from 2015 to 2020 and forecasted data from 2020 to 2027, along with SWOT analysis data of the market. This report includes information by types, by application, by region and by manufacturers or producers.

The recent outburst of the COVID-19 (Corona Virus Disease) has led the global Nano-SiO2 market to render new solutions for combatting with the rising demand for protection against the virus. Due to this outbreak, remote patient monitoring, inpatient monitoring and interactive medicine is expected to gain grip at this time.

Global Nano-SiO2 Market: Segmentation

Global Nano-SiO2 Market Segmentation: By Types

Dry MethodWet Method

Global Nano-SiO2 Market segmentation: By Applications

CoatingPlasticMagnetic MaterialsOthers

Global Nano-SiO2 Market Segmentation: By Region

Global Nano-SiO2 market report categorized the information and data according to the major geographical regions like,

Place Inquiry for Buying or Customization of Report: https://www.apexmarketreports.com/Heavy-Industry/global-nano-sio2-market-by-product-type-dry-322371#inquiry

The Global Nano-SiO2 market is displayed in 13 Chapters:

Chapter 1: Market Overview, Drivers, Restraints and OpportunitiesChapter 2: Market Competition by ManufacturersChapter 3: Production by RegionsChapter 4: Consumption by RegionsChapter 5: Production, By Types, Revenue and Market share by TypesChapter 6: Consumption, By Applications, Market share (%) and Growth Rate by ApplicationsChapter 7: Complete profiling and analysis of ManufacturersChapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expensesChapter 9: Industrial Chain, Sourcing Strategy and Downstream BuyersChapter 10: Marketing Strategy Analysis, Distributors/TradersChapter 11: Market Effect Factors AnalysisChapter 12: Market ForecastChapter 13: Nano-SiO2 Research Findings and Conclusion, Appendix, methodology and data source

View original post here:
Global Nano-SiO2 Market 2020 Impact of COVID-19, Future Growth Analysis and Challenges | PPG, Akzonobel, Sherwin-Williams, RPM International, Axalta...